Difficulties in differential diagnosis of intracranial solitary fibrous tumor: a clinical case
https://doi.org/10.22328/2079-5343-2025-16-4-102-113
Abstract
According to the 5th edition of the World Health Organization (WHO) Classification of Tumors of the Central Nervous System (CNS), published in 2021, solitary fibrous tumor (SFT) has been established as a distinct nosological entity within the category of rare mesenchymal neoplasms, exhibiting a propensity for early recurrence and systemic dissemination.The limited prevalence of SFTs accounts for the scarcity of publications describing their specific neuroimaging patterns, while the clinicopathological features of this tumor have been well-characterized. The lack of robust diagnostic criteria poses significant challenges in differentiating SFTs from other intracranial neoplasms, which require fundamentally distinct therapeutic approaches. This report describes the clinical case of a 40-year-old male patient presenting with headache, systemic dizziness, recurrent syncopal episodes, and generalized tonic-clonic seizures over a two-month period. Brain MRI revealed an extra-axial mass in the left parasellar region, attached with its base to the dura mater, accompanied by perifocal edema, mass effect of the left temporal lobe, prominent vascularity, intense homogeneous contrast enhancement, and elevated perfusion values. The preoperative differential diagnosis included meningioma, schwannoma, dural metastatic lesion, chondrosarcoma, and MALT lymphoma. The «YinYang» sign emerged as the most significant diagnostic criterion, characterized by heterogeneous tumor signal intensity on T2- and T2-FLAIR sequences. The patient underwent microsurgical resection of the tumor. Histopathological examination confirmed the diagnosis of SFT. Thus, the use of a comprehensive multiparametric MRI protocol enables a high-probability preoperative suspicion of SFT, which is critical for surgical planning.
About the Authors
M. M. AkulovRussian Federation
Mikhai M. Akulov — Radiologist
625039, Tyumen, Melnikaite St., 75
R. S. Talybov
Russian Federation
Rustam S. Talybov —Cand. of Sci. (Med.), Radiologist, assistant of the Department of Oncology with a course of radiation diagnostics and radiation therapy
Tyumen, Odesskaya St., 54, 625023
T. M. Kleschevnikova
Russian Federation
Tatyana M. Kleschevnikova — Head physician
625039, Tyumen, Melnikaite St., 75
V. I. Pavlova
Russian Federation
Valeria I. Pavlova — Cand. of Sci. (Med.), Head of the Department of Oncology with a course of radiation diagnostics and radiation therapy
Tyumen, Odesskaya St., 54, 625023
T. N. Trofimova
Russian Federation
Tatyana N. Trofimova — Dr. of Sci. (Med.), Professor, Corresponding Member of the Russian Academy of Sciences, Professor of the radiology department and radiation medicine
197022, St. Petersburg, L’va Tolstogo St., 6–8
References
1. Tolstrup J., Loya A., Aggerholm-Pedersen N., Preisler L., Penninga L. Risk factors for recurrent disease after resection of solitary fibrous tumor: a systematic review // Front Surg. 2024. Jan 31. Vol. 11. Р. 1332421. doi: 10.3389/fsurg.2024.1332421.
2. Chikasue T., Uchiyama Y., Tanoue S., Komaki S., Sugita Y., Abe T. Intracranial solitary fibrous tumor/hemangiopericytoma mimicking cystic meningioma: A case report and literature review // Radiol. Case Rep. 2021. Apr 30; Vol. 16, No. 7. Р. 1637–1642. doi: 10.1016/j.radcr.2021.04.008.
3. Kazazian K., Demicco E.G., de Perrot M., Strauss D., Swallow C.J. Toward Better Understanding and Management of Solitary Fibrous Tumor // Surg. Oncol. Clin. N. Am. 2022 Jul; Vol. 31, No. 3. Р. 459–483. doi: 10.1016/j.soc.2022.03.009.
4. Yamashita D., Suehiro S., Kohno S., Ohue S., Nakamura Y., Kouno D., Ohtsuka Y., Nishikawa M., Matsumoto S., Bernstock J.D., Harada S., Mizuno Y., Kitazawa R., Ohnishi T., Kunieda T. Intracranial anaplastic solitary fibrous tumor/hemangiopericytoma: immunohistochemical markers for definitive diagnosis // Neurosurg. Rev. 2021. Jun; Vol. 44, No. 3. Р. 1591–1600. doi: 10.1007/s10143-020-01348-6.
5. Giannini C., Bouvier C., Demicco E.G., Figarella-Branger D., Fritchie K., Macagno N., Perry A., W. H. O. C. o. T. E. Board, Mesenchymal, non-meningothelial tumours involving the CNS, WHO Classification of Tumours of Central Nervous System, 2021. 5th ed. International Agency for Research on Cancer (IARC). Lyon (France), 2021. Р. 301–305.
6. Georgiesh T., Aggerholm-Pedersen N., Schöffski P., Zhang Y., Napolitano A., Bovée JVMG et al. Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour // Br. J. Cancer. 2022. Vol. 127, No. 10. Р. 1793–1798. doi: 10.1038/s41416-022-01959-4.
7. Tolstrup J., Loya A., Aggerholm-Pedersen N., Preisler L., Penninga L. Risk factors for recurrent disease after resection of solitary fibrous tumor: a systematic review // Front Surg. 2024. Jan 31; Vol. 11. Р. 1332421. doi: 10.3389/fsurg.2024.1332421.
8. Khan AA., Ahuja S., Mankotia D.S., Zaheer S. Intracranial solitary fibrous tumors: Clinical, radiological, and histopathological insights along with review of literature // Pathol. Res. Pract. 2024 Aug; Vol. 260. Р. 155456. doi: 10.1016/j.prp.2024.155456.
9. Morales V.E., de la Paz T.L.A., Santos Vázquez G., Serrano Padilla AE., Moreno Pizarro E. Combined Surgical Approach to Intracranial and Extracranial Hemangiopericytoma: Case Report and Literature Review // Cureus. 2020. Mar 28; Vol. 12, No. 3. Р. e7447. doi: 10.7759/cureus.7447.
10. Eissa L., Bastawi R.A. Skull base «intrinsic» bony mass lesions: conventional., diffusion and perfusion imaging with a proposed imaging approach // Egypt J. Radiol. Nucl Med. 2024. Vol. 55. Р. 188. doi: 10.1186/s43055-024-01350-8.
11. Seo M., Choi Y., Lee S., Kim B.S., Jang J., Shin N.Y., Jung S.L., Ahn KJ. Diagnostic Value of Susceptibility-Weighted MRI in Differentiating Cerebellopontine Angle Schwannoma from Meningioma // Investig Magn. Reson. Imaging. 2020 Mar; Vol. 24, No. 1. Р. 38–45. doi.org/10.13104/imri.2020.24.1.38.
12. El-Abtah ME., Murayi R., Lee J., Recinos P.F., Kshettry V.R. Radiological Differentiation Between Intracranial Meningioma and Solitary Fibrous Tumor/Hemangiopericytoma: A Systematic Literature Review // World Neurosurg. 2023. Feb; Vol. 170. Р. 68–83. doi: 10.1016/j.wneu.2022.11.062.
13. Villanueva-Meyer J.E. Modern day imaging of meningiomas // Handb. Clin. Neurol. 2020. Vol. 169. Р. 177–191. doi: 10.1016/B978-0-12-804280-9.00012-3.
14. Luo X., Jiang H., Liu XJ., Zhang Z., Deng K., Lin F., Jiang J., Wang Y.L., Yu J. Base MRI Imaging Characteristics of Meningioma Patients to Discuss the WHO Classification of Brain Invasion Otherwise Benign Meningiomas // Technol. Cancer Res. Treat. 2023 Jan-Dec; Vol. 22. Р. 15330338231171470. doi: 10.1177/15330338231171470.
15. Yu J., Chen F., Zhang H. et al. Comparative Analysis of the MRI Characteristics of Meningiomas According to the 2016 WHO Pathological Classification // Technology in Cancer Research & Treatment. 2020. Vol. 19. doi: 10.1177/1533033820983287.
16. Liu J., Chen J., Zha Y., Huang Y., Zeng F. Magnetic Resonance Imaging (MRI) Differential Diagnosis of Meningiomas Using ANOVA // Contrast Media Mol. Imaging. 2021. Jul 10; Vol. 2021. Р. 4799116. doi: 10.1155/2021/4799116.
17. Chu J., Ma H., Wang Y., Li K., Liao C., Ding Y. CT and MRI findings of intracranial extraskeletal mesenchymal chondrosarcoma-a case report and literature review // Transl. Cancer Res. 2022. Sep; Vol. 11, No. 9. Р. 3409–3415. doi: 10.21037/tcr-21-2547.
18. Kayahara T., Kurita H., Irie K., Nakahara I., Sasaki T. Intracranial chondrosarcoma located in the region of the posterior clinoid process: a case report // Radiol. Case Rep. 2021. Nov 4; Vol. 17, No. 1. Р. 115–118. doi: 10.1016/j.radcr.2021.09.058.
19. Zhu Z.Y., Wang Y.B., Li H.Y., Wu X.M. Primary intracranial extraskeletal myxoid chondrosarcoma: A case report and review of literature // World J. Clin Cases. 2022. May 6; Vol. 10, No. 13. Р. 4301–4313. doi: 10.12998/wjcc.v10.i13.4301.
20. Yamazawa E., Takahashi S., Shin M., Tanaka S., Takahashi W., Nakamoto T., Suzuki Y., Takami H., Saito N. MRI-Based Radiomics Differentiates Skull Base Chordoma and Chondrosarcoma: A Preliminary Study // Cancers (Basel). 2022. Jul 3; Vol. 14, No. 13. Р. 3264. doi: 10.3390/cancers14133264.
21. Geethapriya S., Govindaraj J., Raghavan B., Ramakrishnan B., Arafath R., Vishwanathan S., Krishna M. Cranial nerve schwannoma — A pictorial essay // Indian J. Radiol. Imaging. 2020. Apr-Jun; Vol. 30, No. 2. Р. 116–125. doi: 10.4103/ijri.IJRI_17_20.
22. Skolnik A.D., Loevner L., Sampathu D.M., Learned K.O. et al. Cranial Nerve Schwannomas: Diagnostic Imaging Approach // Radiographics. 2016. Vol. 36, No. 5. Р. 150199. doi: 10.1148/rg.2016150199.
23. Sacks P., Rahman M. Epidemiology of Brain Metastases // Neurosurg. Clin. N. Am. 2020. Oct; Vol. 31, No. 4. Р. 481–488. doi: 10.1016/j.nec.2020.06.001.
24. Beylerli О., Talybov R., Musaev E., Trofimova Т., Shi H., Ilyasova T., Pavlov V. Cerebrovascular disorders in patients with malignant tumor // Brain Hemorrhages. 2024. Vol. 5, No. 6. Р. 284–292. doi.org/10.1016/j.hest.2024.08.003.
25. Wu H., Beylerli O., Gareev I., Beilerli A., Ilyasova T., Talybov R., Sufianov A., Guo X. Are there reliable multiparametric MRI criteria for differential diagnosis between intracranial meningiomas and solitary intracranial dural metastases? // Oncol Lett. 2023. Jun 28; Vol. 26, No. 2. Р. 350. doi: 10.3892/ol.2023.13936.
26. Alaggio R., Amador C., Anagnostopoulos I., Attygalle A.D., Araujo I.B.O., Berti E., Bhagat G., Borges A.M., Boyer D., Calaminici M., Chadburn A., Chan J.K.C., Cheuk W., Chng W.J., Choi J.K., Chuang S.S., Coupland S.E., Czader M., Dave S.S., de Jong D., Du M.Q., Elenitoba-Johnson K.S., Ferry J., Geyer J., Gratzinger D., Guitart J., Gujral S., Harris M., Harrison C.J., Hartmann S., Hochhaus A., Jansen P.M., Karube K., Kempf W., Khoury J., Kimura H., Klapper W., Kovach A.E., Kumar S., Lazar A.J., Lazzi S., Leoncini L., Leung N., Leventaki V., Li X.Q., Lim M.S., Liu W.P., Louissaint A Jr., Marcogliese A., Medeiros LJ., Michal M., Miranda R.N., Mitteldorf C., Montes-Moreno S., Morice W., Nardi V., Naresh K.N., Natkunam Y., Ng S.B., Oschlies I., Ott G., Parrens M., Pulitzer M., Rajkumar SV., Rawstron A.C., Rech K., Rosenwald A., Said J., Sarkozy C., Sayed S., Saygin C., Schuh A., Sewell W., Siebert R., Sohani A.R., Tooze R., TraverseGlehen A., Vega F., Vergier B., Wechalekar A.D., Wood B., Xerri L., Xiao W. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms // Leukemia. 2022 Jul; Vol. 36, No. 7. Р. 1720–1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22. Erratum in: Leukemia. 2023 Sep; Vol. 37, No. 9. Р. 1944–1951. doi: 10.1038/s41375-023-01962-5.
27. Ren J., Cai L., Ren J., Li S., Ding L. Mucosa associated lymphoid tissue in the central nervous system presenting as meningioma: A case report // Oncol Lett. 2023. May 12; Vol. 26, No. 1. Р. 277. doi: 10.3892/ol.2023.13863.
28. Talybov R., Beylerli O., Mochalov V., Prokopenko A., Ilyasova T., Trofimova T., Sufianov A., Guang Y. Multiparametric MR Imaging Features of Primary CNS Lymphomas // Front Surg. 2022. Apr 18; Vol. 9. Р. 887249. doi: 10.3389/fsurg.2022.887249.
29. Pons-Escoda A., Naval-Baudin P., Velasco R., Vidal N., Majós C. Imaging of Lymphomas Involving the CNS: An Update-Review of the Full Spectrum of Disease with an Emphasis on the World Health Organization Classifications of CNS Tumors 2021 and Hematolymphoid Tumors 2022 // AJNR Am. J. Neuroradiol. 2023. Apr; Vol. 44, No. 4. Р. 358–366. doi: 10.3174/ajnr.A7795.
30. Huang R.Y., Bi W.L., Griffith В. et. al. Imaging and diagnostic advances for intracranial meningiomas // Neuro-Oncology. 2019. January; Vol. 21, Issue 1. P. i44– i61. doi: 10.1093/neuonc/noy143.
31. Li X., Lu Y., Xiong J., Wang D., She D., Kuai X., Geng D., Yin B. Presurgical differentiation between malignant haemangiopericytoma and angiomatous meningioma by a radiomics approach based on texture analysis // J. Neuroradiol. 2019 Sep; Vol. 46, No. 5. Р. 281–287. doi: 10.1016/j.neurad.2019.05.013.
32. Yu Y., Gu F., Luo Y.L., Li S.G., Jia X.F., Gu L.X., Zhang G.P., Liao X. The role of tumor parenchyma and brain cortex signal intensity ratio in differentiating solitary fibrous tumors and meningiomas // Discov. Oncol. 2024. Feb 8; Vol. 15, No. 1. Р. 32. doi: 10.1007/s12672-024-00883-8.
Review
For citations:
Akulov M.M., Talybov R.S., Kleschevnikova T.M., Pavlova V.I., Trofimova T.N. Difficulties in differential diagnosis of intracranial solitary fibrous tumor: a clinical case. Diagnostic radiology and radiotherapy. 2025;16(4):102-113. (In Russ.) https://doi.org/10.22328/2079-5343-2025-16-4-102-113
JATS XML


























